NewMediaWire
Paid press release content from NewMediaWire. The StreetInsider.com news staff was not involved in its creation.
More NewMediaWire
View Older Stories View Newer Stories-
DRCR Enters a New Phase of Growth
-
Metavesco CEO Buys 142,857,142 Common Shares and Provides Shareholder Update
-
Royalty Management Holding Corporation's Subsidiary, The Vault Holdings Corporation, to Launch Private Capital Raise to Expand Operations
-
Lexaria Releases Additional Results From Its Successful Phase 1b Study GLP-1-H24-4
-
Telvantis Inc. Announces Strategic Transaction Involving Telvantis Voice Services
-
ADM Endeavors, Inc. Announces New Joint Venture With Ai CUSTOM
-
Focus Universal Inc. Launches Cost-Effective Commercial IoT for Four Sectors
-
Focus Universal Inc. Forms Sales Division for IoT and SEC Financial Reporting Solutions
-
BioCorRx Provides Update on OTC Markets Quotation Status and Planned Form S1 Filing
-
NeuroOne® Appoints Jason Mills to the Board of Directors
-
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering
-
Golden Matrix Group Appoints Atul Bali, Gaming Industry Expert, as Non-Executive Director
-
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine
-
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA
-
ReelTime Clarifies How Its Reel Intelligence (RI) Achieves Chip-Agnostic Scalability Through Its Fully Distributed Global Intelligence Network Scaling Without Data Centers or Hardware Constraints
-
Skkynet Announces C$2.6 Million Industrial AI Product Development Initiative
-
UPDATE: Golden Cariboo Resources Intersects 0.56 g/t Gold Over 99.84m (327.56 ft)
-
New Facility Expands Production Capacity by Up to 5.8 Times
-
Lexston Announces Appointment of Buddy Doyle to Advisory Board and Stock Option Grant
-
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026
-
Novus Cannabis MedPlan (NDEV) Reports Q3 2025
-
NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results With Product Revenue Growth of 907% to $2.7 Million and 55.8% Gross Margin & Total Revenue Growth of 163% to $9.1 Million for Fisca
-
CleanGo Innovations Inc. Subsidiary Kubera Black Technology to Acquire European Pharmaceutical Leader Freia Farmaceutici Srl, Targeting the Global Health Market
-
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Golden Cariboo Resources Intersects 0.56 g/t Gold Over 99.84m (327.56 ft)
-
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design
-
Skkynet Appoints M&A and Software Executive Shaunna Balady to Advisory Board
-
CHARBONE Confirms the Official Start of Commercial Production of Clean UHP Hydrogen in Sorel-Tracy
-
Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025
-
United Health Products Provides Corporate Update
-
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients
-
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
NeuroOne® to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time
-
GeoVax Addresses Identification of New Mpox Variant
-
Angkor Resources Identifies Gold Prospect on Andong Meas License, Cambodia
-
Aristocrat Group Corporation Launches Gulf Of Merica™ Agave Spirit, Strengthening Revenue Strategy and Expanding Presence in High-Growth Category
-
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board
-
One World Products (to become Isiah Enterprises) Targets December Operational Breakeven; 250,000+ Pounds of Pelletized Rubber Shipped
-
Mitesco's Centcore Sets Sights on Tennessee for Data Center Expansion, Possible Acquisitions and AI
-
GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin® Gene Therapy
-
NeuroOne® Announces Initial Successful Cases Completed With OneRF® Trigeminal Nerve Ablation System at the University Hospitals in Cleveland
-
CHARBONE Taps Air Liquide Veteran Ahead of First Revenue From Flagship Project
-
Noble Mineral Exploration Inc. Announces Diamond Drill Program Which has Commenced in the Timmins Area
-
GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin® in Recurrent Head & Neck Cancer
-
Noble Adopts Shareholder Rights Plan and Engages Investor Relations Consultant
-
CHARBONE to Host Corporate Update Webinar December 16th and Engages Red Cloud as Market Maker
-
Angkor Resources Confirms Mussel Basin Target on Block VIII Oil & Gas License, Cambodia
-
Aztec Expands Drilling Program at the Tombstone Project, Arizona
-
Sigyn CEO Note: Nature Publication Reinforces Rationale for CardioDialysisTM to Address Cardiovascular Disease in Dialysis Patients
-
PickleJar Up All Night Expands to 80+ LRN Stations, Unlocking Millions of New Listeners and New Revenue Pathways for Local Affiliates
